Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment
Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting pre...
Gespeichert in:
Veröffentlicht in: | Biosciences, biotechnology research Asia biotechnology research Asia, 2024-03, Vol.21 (1), p.109-121 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 121 |
---|---|
container_issue | 1 |
container_start_page | 109 |
container_title | Biosciences, biotechnology research Asia |
container_volume | 21 |
creator | Kakad, Smita P. Bharati, Yash R. Kshirsagar, Sanjay J. Dashputre, Neelam Tajanpure, Anjali Kankate, Rani S. Maurya, Pratibha Dhikale, Shalaka |
description | Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting presynaptic dopamine D2/D3 auto receptors selectively at lower dosages. Method: The nanosuspension was prepared by media milling technique for nose to brain delivery. The nose to brain delivery developed an effective route to bypass the BBB and deliver the drug to the brain. Factorial design was used for the designing and optimizing formulation based on various process and formulation factors. The optimized batch further analyzed to determine particle size, PDI, zeta potential, and drug content. With appropriate selection of process parameters like speed and bead amount. The media milling method is one of the effective methodology to reduce particle size and with the help of stabilizers nanoparticles could be stabilised. Result: The average particle size range of nanosuspension batch was observed 100-150 nm with a polydispersity index of 0.0927, Zeta potential +39.14 mV and drug content 88.12 ± 2 %. Conclusion: Intranasal administration is a promising alternative for bypassing the blood-brain barrier, reducing the adverse effects, and lowering the doses. |
doi_str_mv | 10.13005/bbra/3207 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3042007928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3042007928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c997-23376075110a7b1c21c8164c40bec2a346fc97277bf64ee9cc1ea277de19f5e23</originalsourceid><addsrcrecordid>eNotkEFPwzAMhSMEEtPYhV8QiRtSmZO0zXIcgwHSNDjsXqWZq2Vqm5KkSPv3ZIzTs_2ebPkj5J7BExMAxbyuvZ4LDvKKTHhelBkvgV-TCSgpMpYmt2QWwhEAOCiQjE1It9a1t0ZH63rqGrrsbBjbwds90q3uXRjDgH04u43zdOsC0ujos9e2py_Y2h_0J5rqeED65SL20eqWLpMM4WQOLlpDdx517JJ1R24a3Qac_euU7Navu9V7tvl8-1gtN5lRSmZcCFmCLBgDLWtmODMLVuYmhxoN1yIvG6Mkl7JuyhxRGcNQp3aPTDUFcjElD5e1g3ffI4ZYHd3o-3SxEpBzAKn4IqUeLynjXQgemyq93Wl_qhhUf0CrM9DqDFT8AveKaZc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3042007928</pqid></control><display><type>article</type><title>Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kakad, Smita P. ; Bharati, Yash R. ; Kshirsagar, Sanjay J. ; Dashputre, Neelam ; Tajanpure, Anjali ; Kankate, Rani S. ; Maurya, Pratibha ; Dhikale, Shalaka</creator><creatorcontrib>Kakad, Smita P. ; Bharati, Yash R. ; Kshirsagar, Sanjay J. ; Dashputre, Neelam ; Tajanpure, Anjali ; Kankate, Rani S. ; Maurya, Pratibha ; Dhikale, Shalaka</creatorcontrib><description>Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting presynaptic dopamine D2/D3 auto receptors selectively at lower dosages. Method: The nanosuspension was prepared by media milling technique for nose to brain delivery. The nose to brain delivery developed an effective route to bypass the BBB and deliver the drug to the brain. Factorial design was used for the designing and optimizing formulation based on various process and formulation factors. The optimized batch further analyzed to determine particle size, PDI, zeta potential, and drug content. With appropriate selection of process parameters like speed and bead amount. The media milling method is one of the effective methodology to reduce particle size and with the help of stabilizers nanoparticles could be stabilised. Result: The average particle size range of nanosuspension batch was observed 100-150 nm with a polydispersity index of 0.0927, Zeta potential +39.14 mV and drug content 88.12 ± 2 %. Conclusion: Intranasal administration is a promising alternative for bypassing the blood-brain barrier, reducing the adverse effects, and lowering the doses.</description><identifier>ISSN: 0973-1245</identifier><identifier>EISSN: 2456-2602</identifier><identifier>DOI: 10.13005/bbra/3207</identifier><language>eng</language><publisher>Bhopal: Biosciences Biotechnology Research Asia</publisher><subject>Antipsychotics ; Benzamide ; Blood-brain barrier ; Design ; Dopamine ; Dopamine D2 receptors ; Dopamine D3 receptors ; Drug delivery ; Drug development ; Factorial design ; Glycerol ; Intranasal administration ; Metabolism ; Nanoparticles ; Neurotransmission ; Nose ; Particle size ; Particle size determination ; Pharmaceutical industry ; Polydispersity ; Process parameters ; Psychosis ; Psychotropic drugs ; Schizophrenia ; Zeta potential</subject><ispartof>Biosciences, biotechnology research Asia, 2024-03, Vol.21 (1), p.109-121</ispartof><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c997-23376075110a7b1c21c8164c40bec2a346fc97277bf64ee9cc1ea277de19f5e23</cites><orcidid>0000-0002-9218-9810 ; 0000-0003-2219-1664 ; 0000-0001-9962-8700</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kakad, Smita P.</creatorcontrib><creatorcontrib>Bharati, Yash R.</creatorcontrib><creatorcontrib>Kshirsagar, Sanjay J.</creatorcontrib><creatorcontrib>Dashputre, Neelam</creatorcontrib><creatorcontrib>Tajanpure, Anjali</creatorcontrib><creatorcontrib>Kankate, Rani S.</creatorcontrib><creatorcontrib>Maurya, Pratibha</creatorcontrib><creatorcontrib>Dhikale, Shalaka</creatorcontrib><title>Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment</title><title>Biosciences, biotechnology research Asia</title><description>Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting presynaptic dopamine D2/D3 auto receptors selectively at lower dosages. Method: The nanosuspension was prepared by media milling technique for nose to brain delivery. The nose to brain delivery developed an effective route to bypass the BBB and deliver the drug to the brain. Factorial design was used for the designing and optimizing formulation based on various process and formulation factors. The optimized batch further analyzed to determine particle size, PDI, zeta potential, and drug content. With appropriate selection of process parameters like speed and bead amount. The media milling method is one of the effective methodology to reduce particle size and with the help of stabilizers nanoparticles could be stabilised. Result: The average particle size range of nanosuspension batch was observed 100-150 nm with a polydispersity index of 0.0927, Zeta potential +39.14 mV and drug content 88.12 ± 2 %. Conclusion: Intranasal administration is a promising alternative for bypassing the blood-brain barrier, reducing the adverse effects, and lowering the doses.</description><subject>Antipsychotics</subject><subject>Benzamide</subject><subject>Blood-brain barrier</subject><subject>Design</subject><subject>Dopamine</subject><subject>Dopamine D2 receptors</subject><subject>Dopamine D3 receptors</subject><subject>Drug delivery</subject><subject>Drug development</subject><subject>Factorial design</subject><subject>Glycerol</subject><subject>Intranasal administration</subject><subject>Metabolism</subject><subject>Nanoparticles</subject><subject>Neurotransmission</subject><subject>Nose</subject><subject>Particle size</subject><subject>Particle size determination</subject><subject>Pharmaceutical industry</subject><subject>Polydispersity</subject><subject>Process parameters</subject><subject>Psychosis</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><subject>Zeta potential</subject><issn>0973-1245</issn><issn>2456-2602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNotkEFPwzAMhSMEEtPYhV8QiRtSmZO0zXIcgwHSNDjsXqWZq2Vqm5KkSPv3ZIzTs_2ebPkj5J7BExMAxbyuvZ4LDvKKTHhelBkvgV-TCSgpMpYmt2QWwhEAOCiQjE1It9a1t0ZH63rqGrrsbBjbwds90q3uXRjDgH04u43zdOsC0ujos9e2py_Y2h_0J5rqeED65SL20eqWLpMM4WQOLlpDdx517JJ1R24a3Qac_euU7Navu9V7tvl8-1gtN5lRSmZcCFmCLBgDLWtmODMLVuYmhxoN1yIvG6Mkl7JuyhxRGcNQp3aPTDUFcjElD5e1g3ffI4ZYHd3o-3SxEpBzAKn4IqUeLynjXQgemyq93Wl_qhhUf0CrM9DqDFT8AveKaZc</recordid><startdate>20240330</startdate><enddate>20240330</enddate><creator>Kakad, Smita P.</creator><creator>Bharati, Yash R.</creator><creator>Kshirsagar, Sanjay J.</creator><creator>Dashputre, Neelam</creator><creator>Tajanpure, Anjali</creator><creator>Kankate, Rani S.</creator><creator>Maurya, Pratibha</creator><creator>Dhikale, Shalaka</creator><general>Biosciences Biotechnology Research Asia</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-9218-9810</orcidid><orcidid>https://orcid.org/0000-0003-2219-1664</orcidid><orcidid>https://orcid.org/0000-0001-9962-8700</orcidid></search><sort><creationdate>20240330</creationdate><title>Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment</title><author>Kakad, Smita P. ; Bharati, Yash R. ; Kshirsagar, Sanjay J. ; Dashputre, Neelam ; Tajanpure, Anjali ; Kankate, Rani S. ; Maurya, Pratibha ; Dhikale, Shalaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c997-23376075110a7b1c21c8164c40bec2a346fc97277bf64ee9cc1ea277de19f5e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antipsychotics</topic><topic>Benzamide</topic><topic>Blood-brain barrier</topic><topic>Design</topic><topic>Dopamine</topic><topic>Dopamine D2 receptors</topic><topic>Dopamine D3 receptors</topic><topic>Drug delivery</topic><topic>Drug development</topic><topic>Factorial design</topic><topic>Glycerol</topic><topic>Intranasal administration</topic><topic>Metabolism</topic><topic>Nanoparticles</topic><topic>Neurotransmission</topic><topic>Nose</topic><topic>Particle size</topic><topic>Particle size determination</topic><topic>Pharmaceutical industry</topic><topic>Polydispersity</topic><topic>Process parameters</topic><topic>Psychosis</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><topic>Zeta potential</topic><toplevel>online_resources</toplevel><creatorcontrib>Kakad, Smita P.</creatorcontrib><creatorcontrib>Bharati, Yash R.</creatorcontrib><creatorcontrib>Kshirsagar, Sanjay J.</creatorcontrib><creatorcontrib>Dashputre, Neelam</creatorcontrib><creatorcontrib>Tajanpure, Anjali</creatorcontrib><creatorcontrib>Kankate, Rani S.</creatorcontrib><creatorcontrib>Maurya, Pratibha</creatorcontrib><creatorcontrib>Dhikale, Shalaka</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Biosciences, biotechnology research Asia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kakad, Smita P.</au><au>Bharati, Yash R.</au><au>Kshirsagar, Sanjay J.</au><au>Dashputre, Neelam</au><au>Tajanpure, Anjali</au><au>Kankate, Rani S.</au><au>Maurya, Pratibha</au><au>Dhikale, Shalaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment</atitle><jtitle>Biosciences, biotechnology research Asia</jtitle><date>2024-03-30</date><risdate>2024</risdate><volume>21</volume><issue>1</issue><spage>109</spage><epage>121</epage><pages>109-121</pages><issn>0973-1245</issn><eissn>2456-2602</eissn><abstract>Background: This research was aimed with the development of antipsychotic drug delivery for olfactory administration which could deliver drug to the brain. Amisulpride is a psychoactive drug that belongs to the benzamide derivatives class. It enhances dopaminergic neurotransmission by inhibiting presynaptic dopamine D2/D3 auto receptors selectively at lower dosages. Method: The nanosuspension was prepared by media milling technique for nose to brain delivery. The nose to brain delivery developed an effective route to bypass the BBB and deliver the drug to the brain. Factorial design was used for the designing and optimizing formulation based on various process and formulation factors. The optimized batch further analyzed to determine particle size, PDI, zeta potential, and drug content. With appropriate selection of process parameters like speed and bead amount. The media milling method is one of the effective methodology to reduce particle size and with the help of stabilizers nanoparticles could be stabilised. Result: The average particle size range of nanosuspension batch was observed 100-150 nm with a polydispersity index of 0.0927, Zeta potential +39.14 mV and drug content 88.12 ± 2 %. Conclusion: Intranasal administration is a promising alternative for bypassing the blood-brain barrier, reducing the adverse effects, and lowering the doses.</abstract><cop>Bhopal</cop><pub>Biosciences Biotechnology Research Asia</pub><doi>10.13005/bbra/3207</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9218-9810</orcidid><orcidid>https://orcid.org/0000-0003-2219-1664</orcidid><orcidid>https://orcid.org/0000-0001-9962-8700</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1245 |
ispartof | Biosciences, biotechnology research Asia, 2024-03, Vol.21 (1), p.109-121 |
issn | 0973-1245 2456-2602 |
language | eng |
recordid | cdi_proquest_journals_3042007928 |
source | EZB-FREE-00999 freely available EZB journals |
subjects | Antipsychotics Benzamide Blood-brain barrier Design Dopamine Dopamine D2 receptors Dopamine D3 receptors Drug delivery Drug development Factorial design Glycerol Intranasal administration Metabolism Nanoparticles Neurotransmission Nose Particle size Particle size determination Pharmaceutical industry Polydispersity Process parameters Psychosis Psychotropic drugs Schizophrenia Zeta potential |
title | Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T11%3A06%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fabrication%20of%20Amisulpride%20Nanosuspension%20for%20Nose%20to%20Brain%20Delivery%20in%20the%20Potential%20Antipsychotic%20Treatment&rft.jtitle=Biosciences,%20biotechnology%20research%20Asia&rft.au=Kakad,%20Smita%20P.&rft.date=2024-03-30&rft.volume=21&rft.issue=1&rft.spage=109&rft.epage=121&rft.pages=109-121&rft.issn=0973-1245&rft.eissn=2456-2602&rft_id=info:doi/10.13005/bbra/3207&rft_dat=%3Cproquest_cross%3E3042007928%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3042007928&rft_id=info:pmid/&rfr_iscdi=true |